• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡氏行为状态评分和视觉模拟评分是儿童时期接受异基因造血干细胞移植的长期 AYA 幸存者生活质量的简单指标。

Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood.

机构信息

Pediatric Medical Center, Ehime Prefectural Central Hospital, 83 Kasuga-machi, Matsuyama-city, Ehime, 790-0024, Japan.

Division of Health Sciences and Nursing Department of Family Nursing, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.

出版信息

Int J Hematol. 2022 Nov;116(5):787-797. doi: 10.1007/s12185-022-03426-5. Epub 2022 Sep 3.

DOI:10.1007/s12185-022-03426-5
PMID:36056987
Abstract

The purpose of this study was to investigate Karnofsky performance status (KPS) scores and visual analogue scale (VAS) scores to explain which domains in the standardized self-reported quality of life (QOL) are instrumental for long-term hematopoietic stem cell transplantation (HSCT) survivors. We conducted a nationwide cross-sectional questionnaire study on 221 survivors with allogeneic-HSCT in 28 pediatric centers. Patient-reported QOL was assessed at a single time point using the 36-item Short-Form Survey (SF-36), the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT), and VAS scores. KPS scores were significantly correlated with both physical and role component summary scores of the SF-36, while the VAS provided by the patient (VASpt) was significantly correlated with the mental component summary score of the SF-36 and many subscales of the FACT-BMT. The VAS provided by the participants' attending physician (VASdoc) was correlated well with KPS scores. A VASpt score more than 40% lower than KPS scores suggested mental health problems. In conclusion, KPS scores might be considered as an indicator for physical and role/social components and VASpt score as an indicator for mental components and HSCT-specific QOL.

摘要

本研究旨在探讨 Karnofsky 表现状态(KPS)评分和视觉模拟评分(VAS),以解释标准化自我报告生活质量(QOL)的哪些领域对长期造血干细胞移植(HSCT)幸存者具有重要意义。我们在 28 个儿科中心对 221 名接受异基因-HSCT 的幸存者进行了一项全国性的横断面问卷调查研究。使用 36 项简短健康调查问卷(SF-36)、癌症治疗功能评估-骨髓移植(FACT-BMT)和 VAS 评分在单一时间点评估患者报告的 QOL。KPS 评分与 SF-36 的身体和角色成分综合评分显著相关,而患者提供的 VAS(VASpt)与 SF-36 的心理成分综合评分以及 FACT-BMT 的许多子量表显著相关。参与者主治医生提供的 VAS(VASdoc)与 KPS 评分相关性较好。VASpt 评分比 KPS 评分低 40%以上提示存在心理健康问题。总之,KPS 评分可被视为身体和角色/社会成分的指标,VASpt 评分可被视为心理成分和 HSCT 特异性 QOL 的指标。

相似文献

1
Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood.卡氏行为状态评分和视觉模拟评分是儿童时期接受异基因造血干细胞移植的长期 AYA 幸存者生活质量的简单指标。
Int J Hematol. 2022 Nov;116(5):787-797. doi: 10.1007/s12185-022-03426-5. Epub 2022 Sep 3.
2
Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan.慢性移植物抗宿主病对小儿造血干细胞移植幸存者生活质量的影响:基于视觉模拟量表的评估及评估者间差异——日本的一项横断面观察研究
Int J Hematol. 2022 Jan;115(1):123-128. doi: 10.1007/s12185-021-03227-2. Epub 2021 Oct 3.
3
Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation.与亲缘相合供者移植相比,单倍体相合干细胞移植的长期生存者具有更高的生活质量。
J Transl Med. 2022 Dec 14;20(1):596. doi: 10.1186/s12967-022-03803-y.
4
Quality of Life following Allogeneic Stem Cell Transplantation for Patients Age >60 Years with Acute Myelogenous Leukemia.60 岁以上急性髓系白血病患者接受异基因造血干细胞移植后的生活质量。
Biol Blood Marrow Transplant. 2020 Aug;26(8):1527-1533. doi: 10.1016/j.bbmt.2020.04.020. Epub 2020 May 15.
5
Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma.评价自体造血干细胞移植对老年淋巴瘤患者生活质量的影响。
Biol Blood Marrow Transplant. 2020 Jan;26(1):157-161. doi: 10.1016/j.bbmt.2019.09.007. Epub 2019 Sep 12.
6
Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.异基因造血细胞移植后根据受影响器官和慢性移植物抗宿主病严重程度的生活质量。
Biol Blood Marrow Transplant. 2017 Oct;23(10):1749-1758. doi: 10.1016/j.bbmt.2017.06.011. Epub 2017 Jun 29.
7
Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5.异基因造血细胞移植前后生活质量及其纵向变化对预后的影响:一项使用简明健康调查量表(SF-12)和欧洲五维健康量表(EuroQol 5D)的前瞻性研究
Transplant Cell Ther. 2021 Nov;27(11):935.e1-935.e9. doi: 10.1016/j.jtct.2021.07.026. Epub 2021 Aug 8.
8
Long-Term Recipient Health-Related Quality of Life and Donor-Recipient Relationship following Sibling Pediatric Hematopoietic Stem Cell Transplantation.同胞儿童造血干细胞移植后受体的健康相关生活质量和供受者关系的长期变化
Biol Blood Marrow Transplant. 2020 Feb;26(2):401-406. doi: 10.1016/j.bbmt.2019.10.009. Epub 2019 Oct 14.
9
PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.PROMIS 测量可用于评估长期造血细胞移植幸存者的症状和功能。
Cancer. 2018 Feb 15;124(4):841-849. doi: 10.1002/cncr.31089. Epub 2017 Oct 26.
10
Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.缓解与活动慢性移植物抗宿主病:对移植后生活质量的影响。
Biol Blood Marrow Transplant. 2019 Sep;25(9):1851-1858. doi: 10.1016/j.bbmt.2019.05.016. Epub 2019 May 24.

引用本文的文献

1
Impact of multidisciplinary collaborative jejunal nutrition care on nutritional status and quality of life in severely burned patients.多学科协作空肠营养护理对重度烧伤患者营养状况及生活质量的影响
Medicine (Baltimore). 2025 Apr 4;104(14):e41965. doi: 10.1097/MD.0000000000041965.
2
Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients.将患者报告的结局数据纳入异基因造血细胞移植受者的预测计算器。
Cancer. 2024 May 15;130(10):1826-1835. doi: 10.1002/cncr.35189. Epub 2024 Jan 10.
3
Effect of HER2 expression status on the prognosis of patients with HR/HER2 advanced breast cancer undergoing advanced first‑line endocrine therapy.

本文引用的文献

1
Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.评价多发性骨髓瘤患者门诊自体干细胞移植后未计划入院率的表现状态和造血细胞移植特异性合并症指数。
Biol Blood Marrow Transplant. 2017 Oct;23(10):1641-1645. doi: 10.1016/j.bbmt.2017.06.001. Epub 2017 Jun 8.
2
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.骨髓增生异常综合征患者接受异基因造血细胞移植后预后的评分系统
J Clin Oncol. 2016 Jun 1;34(16):1864-71. doi: 10.1200/JCO.2015.65.0515. Epub 2016 Apr 4.
3
HER2表达状态对接受一线晚期内分泌治疗的HR/HER2阳性晚期乳腺癌患者预后的影响。
Oncol Lett. 2023 May 26;26(1):299. doi: 10.3892/ol.2023.13885. eCollection 2023 Jul.
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.
异基因移植为一部分自体移植后复发的弥漫性大B细胞淋巴瘤(DLBCL)患者带来持久缓解。
Br J Haematol. 2016 Jul;174(2):235-48. doi: 10.1111/bjh.14046. Epub 2016 Mar 15.
4
Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.儿童造血细胞移植幸存者的迟发效应监测建议:一份儿童肿瘤学组报告。
Biol Blood Marrow Transplant. 2016 May;22(5):782-95. doi: 10.1016/j.bbmt.2016.01.023. Epub 2016 Jan 21.
5
Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data).移植登记统一管理程序2(TRUMP2)介绍:TRUMP数据分析脚本,第一部分(非HLA相关数据的变量)
Int J Hematol. 2016 Jan;103(1):3-10. doi: 10.1007/s12185-015-1894-x. Epub 2015 Nov 7.
6
Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series.降低治疗相关死亡率并未改善高危多发性骨髓瘤异基因清髓性造血细胞移植的疗效:密歇根大学前瞻性系列研究
Biol Blood Marrow Transplant. 2016 Jan;22(1):54-60. doi: 10.1016/j.bbmt.2015.07.021. Epub 2015 Jul 26.
7
Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.儿童急性髓系白血病缓解后化疗与 BMT 后幸存者的健康状况和生活质量比较:来自儿童肿瘤组的报告。
Pediatr Blood Cancer. 2014 Apr;61(4):729-36. doi: 10.1002/pbc.24881. Epub 2013 Nov 27.
8
A French cohort of childhood leukemia survivors: impact of hematopoietic stem cell transplantation on health status and quality of life.一项法国儿童白血病幸存者队列研究:造血干细胞移植对健康状况和生活质量的影响。
Biol Blood Marrow Transplant. 2013 Jul;19(7):1065-72. doi: 10.1016/j.bbmt.2013.04.015. Epub 2013 Apr 22.
9
Health-related quality of life of hematopoietic stem cell transplant childhood survivors: state of the science.造血干细胞移植儿童幸存者的健康相关生活质量:科学现状
J Pediatr Oncol Nurs. 2011 Jul-Aug;28(4):191-202. doi: 10.1177/1043454211408100. Epub 2011 Jun 2.
10
Health-related quality of life (HRQoL): the impact of medical and demographic variables upon pediatric recipients of hematopoietic stem cell transplantation.健康相关生活质量(HRQoL):医学和人口统计学变量对造血干细胞移植儿科受者的影响。
Pediatr Blood Cancer. 2011 Dec 15;57(7):1179-85. doi: 10.1002/pbc.23133. Epub 2011 Apr 21.